• Je něco špatně v tomto záznamu ?

Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic

HJ. Anders, A. Bruchfeld, GM. Fernandez Juarez, J. Floege, D. Goumenos, K. Turkmen, C. van Kooten, V. Tesar, M. Segelmark,

. 2020 ; 35 (6) : 920-925. [pub] 20200601

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, směrnice pro lékařskou praxi, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20024989

The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients. The aim of the present review of the Immunonephrology Working Group of the European Renal Association-European Dialysis and Transplant Association is to provide recommendations for the management of patients with immune-mediated kidney diseases based on the available evidence, similar circumstances with other infectious organisms and expert opinions from across Europe. Such recommendations may help to minimize the risk of encountering COVID-19 or developing complications during COVID-19 in patients with immune-mediated kidney disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20024989
003      
CZ-PrNML
005      
20201222153633.0
007      
ta
008      
201125s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ndt/gfaa112 $2 doi
035    __
$a (PubMed)32445573
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Anders, Hans-Joachim $u Division of Nephrology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Munich, Germany.
245    10
$a Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic / $c HJ. Anders, A. Bruchfeld, GM. Fernandez Juarez, J. Floege, D. Goumenos, K. Turkmen, C. van Kooten, V. Tesar, M. Segelmark,
520    9_
$a The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients. The aim of the present review of the Immunonephrology Working Group of the European Renal Association-European Dialysis and Transplant Association is to provide recommendations for the management of patients with immune-mediated kidney diseases based on the available evidence, similar circumstances with other infectious organisms and expert opinions from across Europe. Such recommendations may help to minimize the risk of encountering COVID-19 or developing complications during COVID-19 in patients with immune-mediated kidney disease.
650    _2
$a antivirové látky $7 D000998
650    _2
$a Betacoronavirus $7 D000073640
650    _2
$a koronavirové infekce $x komplikace $x imunologie $x terapie $7 D018352
650    _2
$a lidé $7 D006801
650    _2
$a imunosupresiva $x terapeutické užití $7 D007166
650    _2
$a nemoci ledvin $x komplikace $x imunologie $x terapie $7 D007674
650    _2
$a nefrologie $x normy $7 D009398
650    _2
$a pandemie $7 D058873
650    _2
$a virová pneumonie $x komplikace $x imunologie $x terapie $7 D011024
650    _2
$a dialýza ledvin $7 D006435
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a společnosti lékařské $7 D012955
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bruchfeld, Annette $u Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. Division of Diagnostics and Specialist Medicine, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
700    1_
$a Fernandez Juarez, Gema Maria $u Department of Nephrology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
700    1_
$a Floege, Jürgen $u Division of Nephrology, RWTH Aachen University Hospital, Aachen, Germany.
700    1_
$a Goumenos, Dimitrios $u Department of Nephrology and Renal Transplantation, Patras University Hospital, Patras, Greece.
700    1_
$a Turkmen, Kultigin $u Division of Nephrology, Department of Internal Medicine, Necmettin Erbakan University, Konya, Turkey.
700    1_
$a van Kooten, Cees $u Division of Nephrology and Transplant Medicine, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
700    1_
$a Tesar, Vladimir $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Segelmark, Mårten $u Division of Diagnostics and Specialist Medicine, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden. Division of Nephrology, Department of Clinical Sciences Lund, Lund University and Skåne University Hospital, Lund, Sweden.
773    0_
$w MED00010288 $t Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association $x 1460-2385 $g Roč. 35, č. 6 (2020), s. 920-925
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32445573 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222153629 $b ABA008
999    __
$a ok $b bmc $g 1599134 $s 1115675
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 35 $c 6 $d 920-925 $e 20200601 $i 1460-2385 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace